Protocol Ledger

NCT03371719 · Phase II · ACTIVE NOT RECRUITING

Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial

Interventional Phase II clinical trial protocol NCT03371719 sponsored by NRG Oncology in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2018-06-20 Enrollment: 298 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03371719
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)298 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03371719
Protocol FieldVerified Registry Value
NCT IdentifierNCT03371719
Consolidated Lead SponsorNRG Oncology
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment298 participants (ACTUAL)
Registered Start Date2018-06-20
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT03371719
Hospital Research SiteLocationSite Profile
University of Arkansas for Medical SciencesLittle Rock, AROpen Hospital Dossier ->
Alta Bates Summit Medical Center-Herrick CampusBerkeley, CAOpen Hospital Dossier ->
Los Angeles General Medical CenterLos Angeles, CAOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI